oxycodone hydrochloride/aspirin / Generic mfg. - LARVOL DELTA

Postoperative Pain Control in Septum and Sinus Surgery (clinicaltrials.gov) - P4 | N=65 | Completed | Sponsor: William Beaumont Hospitals | Recruiting ➔ Completed | N=200 ➔ 65 | Trial completion date: Nov 2023 ➔ Sep 2022

Enrollment change • Trial completion • Trial completion date • Otorhinolaryngology • Pain

Postoperative Pain Control in Septum and Sinus Surgery (clinicaltrials.gov) - P4; N=200; Recruiting; Sponsor: William Beaumont Hospitals; Trial completion date: Nov 2022 ➔ Nov 2023; Trial primary completion date: Nov 2021 ➔ Nov 2022

Trial completion date • Trial primary completion date • Otorhinolaryngology • Pain

"I was 17 and a molar came in impacted and got infected. Looked like I had a golf ball in my mouth. Two weeks of percodan (aspirin) and antibiotics, yuck. Oral surgery to remove the tooth, wrecked my stomach for a month." (@PhilipFDaniels1)

Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients (clinicaltrials.gov) - P2; N=20; Not yet recruiting; Sponsor: Medical College of Wisconsin

Clinical • New P2 trial • Head and Neck Cancer • Mucositis • Oncology • Pain • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck

Postoperative Pain Control in Septum and Sinus Surgery (clinicaltrials.gov) - P4; N=200; Recruiting; Sponsor: William Beaumont Hospitals; Trial completion date: Nov 2021 ➔ Nov 2022; Trial primary completion date: Nov 2020 ➔ Nov 2021

Trial completion date • Trial primary completion date • Otorhinolaryngology • Pain

Postoperative Pain Control in Septum and Sinus Surgery (clinicaltrials.gov) - P4; N=200; Recruiting; Sponsor: William Beaumont Hospitals; Not yet recruiting ➔ Recruiting

Enrollment open

Postoperative Pain Control in Septum and Sinus Surgery (clinicaltrials.gov) - P4; N=200; Not yet recruiting; Sponsor: William Beaumont Hospitals

New P4 trial

Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion (clinicaltrials.gov) - P3; N=156; Completed; Sponsor: Study Investigator-Sponsor; Active, not recruiting ➔ Completed

Clinical • Trial completion

Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion (clinicaltrials.gov) - P3; N=156; Active, not recruiting; Sponsor: Study Investigator-Sponsor; Recruiting ➔ Active, not recruiting

Clinical • Enrollment closed

DexMab: Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion (clinicaltrials.gov) - P3; N=156; Recruiting; Sponsor: Study Sponsor-Investigator; Trial completion date: Oct 2019 ➔ Jun 2019; Trial primary completion date: Apr 2019 ➔ Jun 2019

Clinical • Trial completion date • Trial primary completion date